Drug Profile
Anti-tumour necrosis factor-alpha antibody oral
Alternative Names: Anti-TNF-alpha antibody oral; Arthrofoon; ArtrofoonLatest Information Update: 28 Jun 2007
Price :
$50
*
At a glance
- Originator Materia Medica Holding Research and Production Company
- Developer Materia Medica Holdings
- Class Antibodies
- Mechanism of Action Tumour necrosis factor alpha inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Osteoarthritis; Rheumatoid arthritis